Investments in and Advances to Joint Ventures - Schedule of Reconciliation of Consolidated Joint Venture Equity (Detail) - USD ($) $ in Thousands |
Jun. 30, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Schedule Of Equity Method Investments [Line Items] | ||
| Company's share of accumulated equity | $ 28,220 | $ 35,782 |
| Basis differentials | 2,329 | 1,099 |
| Deferred leasing and development fees, net of portion related to the Company's interest | 0 | (136) |
| Amounts payable to the Company | 2,027 | 2,627 |
| Investments in and Advances to Joint Ventures, net | $ 32,576 | $ 39,372 |
| X | ||||||||||
- Definition The reporting entity's share of accumulated common equity in the combined entities in which the reporting entity accounts for the investment using the equity method of accounting. No definition available.
|
| X | ||||||||||
- Definition This element represents the Company's portion of leasing and deferred development fees earned from equity method investments and are amortized over the remaining life of the related asset. No definition available.
|
| X | ||||||||||
- Definition Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of investment in equity method investee and investment in and advance to affiliate. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount due from parties in nontrade transactions, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|